HORIBA India, a “MNC of Japanese origin”, recently organized “HORIBA Connect” an event where global leaders and premier Indian customers & stakeholders gathered to discuss investment plans and business avenues in India. HORIBA globally runs its business under 5 verticals i.e. Automotive Testing Systems, Medical, Process & Environment, Scientific, Semi-conductors. HORIBA’s unbeatable technology is world-famous for all types of analytic industries like automotive testing, medical, research, environmental check etc.

The major highlights included business updates, corporate structure, future growth prospects in various segments in India & SAARC nations. In a special coverage through Medgate Today, the Leadership team shared idea about their plan & prospects related to medical business in India. 

HORIBA Group, Chief Operating Officer, Mr. Juichi Saito, visited India specially to attend this event and shared his views on Indian medical technology market and HORIBA’s future plans to serve the healthcare industry. Dr. Rajeev Gautam, President HORIBA India, shared his views, strategies and initiatives about customer delight. Touching human lives through its world-class analytical technology utilizing various innovative initiatives like HABX (Hematology Analyzer Based Xchanges), HORIBA interpretation training (HIT) & HORIBA Operational Training (HOT) is what the leadership is continuously striving and driving enthusiastically. These are conducted in world-class digital class-rooms and laboratory set-ups designed and created at their International Training center facility at their head-office in New Delhi, India.

HORIBA Connect was also attended by Dr. Arvind Lal, Founder & Managing Director of India’s largest Laboratory chain network, Dr. Lal Path labs. He appreciated HORIBA medical technology and their decade long relation with the company using 160 high-end instruments. 

HORIBA Medical has globally established 6 International Training centers and India is one of them producing world-class medical technology engineers in the field of Hematology and Clinical Chemistry.

This event was also attended by delegates from various sectors of the industry like Maruti Suzuki, CPCB, Deloitte, KPMG etc.  Dr. Rajeev Gautam, who is leading the operations in India is taking all the 5 segments of HORIBA Group to unbelievable heights with his exemplary leadership. 

HORIBA India entered Indian healthcare market around a decade ago with just Hematology products and is now gradually growing its business in Clinical Chemistry and Coagulation markets. HORIBA’s world-class technology products are manufactured under stringent internationally approved standards of GMP and are well appreciated in several western and European countries.

HORIBA is coming up with its state-of-the-art facility to manufacture Reagents in Nagpur, Maharashtra poised to be the largest Hematology Reagent manufacturing facility in India.